QUAKER HOUGHTON ANNOUNCES SECOND QUARTER 2023 RESULTS
- Net sales of
in Q2'23, an increase of$495.4 million 1% compared to Q2'22 driven by value-based pricing initiatives - Q2'23 net income of
$29.3 million and earnings per diluted share of$1.63 - Q2'23 non-GAAP net income of
and non-GAAP earnings per diluted share of$34.8 million $1.93 - Delivered adjusted EBITDA of
in Q2'23, a$80.2 million 37% increase compared to in Q2'22$58.5 million - Generated
of operating cash flow year-to-date; net debt to adjusted EBITDA improved to 2.3x$116.1 million
Three Months Ended | Six Months Ended | ||||||
($ in thousands, except per share data) | 2023 | 2022 | 2023 | 2022 | |||
Net sales | $ 495,444 | $ 492,388 | $ 995,592 | $ 966,559 | |||
Net income attributable to Quaker Chemical Corporation | 29,346 | 14,343 | 58,880 | 34,159 | |||
Net income attributable to Quaker Chemical Corporation | 1.63 | 0.80 | 3.27 | 1.91 | |||
Non-GAAP net income * | 34,774 | 23,675 | 68,766 | 49,145 | |||
Non-GAAP Earnings per diluted share * | 1.93 | 1.32 | 3.82 | 2.74 | |||
Adjusted EBITDA * | 80,242 | 58,491 | 159,033 | 118,935 |
* | Refer to the Non-GAAP Measures and Reconciliations section below for additional information |
Second Quarter 2023 Consolidated Results
Second quarter of 2023 net sales were
The Company reported net income in the second quarter of 2023 of
Andy Tometich, Chief Executive Officer and President, commented, "In the second quarter, Quaker Houghton once again successfully managed through a very challenging operating environment and achieved strong results. Despite market conditions, we have made meaningful progress improving the profitability of our business through our margin initiatives and delivered double-digit year-over-year earnings growth and solid cash flow.
Looking ahead, we expect the current uneven end market environment will persist at least through the end of the year. We will continue to execute on what we can control, including investing to strengthen the business, delivering value to customers, advancing our strategic initiatives, and delivering strong year-over-year growth in earnings and cash flow. I am confident in our strategy and believe these actions best position Quaker Houghton to deliver on our profitable growth potential."
Second Quarter 2023 Segment Results
During the first quarter of 2023, the Company reorganized its executive management team to align with its new business structure. The Company's new structure includes three reportable segments: (i)
The Company's three and six months of June 30, 2023 operating performance of each of its three reportable segments, (i)
Three Months Ended | Six Months Ended | ||||||
2023 | 2022 | 2023 | 2022 | ||||
Net Sales * | |||||||
$ 253,219 | $ 235,809 | $ 504,632 | $ 447,900 | ||||
EMEA | 143,533 | 145,535 | 295,982 | 292,354 | |||
98,692 | 111,044 | 194,978 | 226,305 | ||||
Total net sales | $ 495,444 | $ 492,388 | $ 995,592 | $ 966,559 | |||
Segment operating earnings * | |||||||
$ 69,007 | $ 52,137 | $ 135,132 | $ 97,316 | ||||
EMEA | 25,583 | 20,076 | 53,154 | 43,324 | |||
27,989 | 24,922 | 55,641 | 49,423 | ||||
Total segment operating earnings | $ 122,579 | $ 97,135 | $ 243,927 | $ 190,063 |
* | Refer to the Segment Measures and Reconciliations section below for additional information |
Net sales in the
Compared to the first quarter of 2023, net sales increased in the
Operating earnings increased in all three segments in the second quarter of 2023 compared to the prior year, primarily driven by an improvement in operating margins in all segments. Operating margins increased in the
Cash Flow and Liquidity Highlights
Net cash provided by operating activities was
As of June 30, 2023, the Company's total gross debt was
Non-GAAP Measures and Reconciliations
The information included in this press release includes non-GAAP (unaudited) financial information that includes EBITDA, adjusted EBITDA, adjusted EBITDA margin, non-GAAP operating income, non-GAAP operating margin, non-GAAP net income and non-GAAP earnings per diluted share. The Company believes these non-GAAP financial measures provide meaningful supplemental information as they enhance a reader's understanding of the financial performance of the Company, are indicative of future operating performance of the Company, and facilitate a comparison among fiscal periods, as the non-GAAP financial measures exclude items that are not considered indicative of future operating performance or not considered core to the Company's operations. Non-GAAP results are presented for supplemental informational purposes only and should not be considered a substitute for the financial information presented in accordance with GAAP. In addition, our definitions of EBITDA, adjusted EBITDA, adjusted EBITDA margin, non-GAAP operating income, non-GAAP operating margin, non-GAAP net income and non-GAAP earnings per diluted share, as discussed and reconciled below to the most comparable respective GAAP measures, may not be comparable to similarly named measures reported by other companies
The Company presents EBITDA which is calculated as net income attributable to the Company before depreciation and amortization, interest expense, net, and taxes on income before equity in net income of associated companies. The Company also presents adjusted EBITDA which is calculated as EBITDA plus or minus certain items that are not considered indicative of future operating performance or not considered core to the Company's operations. In addition, the Company presents non-GAAP operating income which is calculated as operating income plus or minus certain items that are not considered indicative of future operating performance or not considered core to the Company's operations. Adjusted EBITDA margin and non-GAAP operating margin are calculated as the percentage of adjusted EBITDA and non-GAAP operating income to consolidated net sales, respectively. The Company believes these non-GAAP measures provide transparent and useful information and are widely used by investors, analysts, and peers in our industry as well as by management in assessing the operating performance of the Company on a consistent basis.
Additionally, the Company presents non-GAAP net income and non-GAAP earnings per diluted share as additional performance measures. Non-GAAP net income is calculated as adjusted EBITDA, defined above, less depreciation and amortization, interest expense, net, and taxes on income before equity in net income of associated companies, in each case adjusted, as applicable, for any depreciation, amortization, interest or tax impacts resulting from the non-core items identified in the reconciliation of net income attributable to the Company to adjusted EBITDA. Non-GAAP earnings per diluted share is calculated as non-GAAP net income per diluted share as accounted for under the "two-class share method." The Company believes that non-GAAP net income and non-GAAP earnings per diluted share provide transparent and useful information and are widely used by investors, analysts, and peers in our industry as well as by management in assessing the operating performance of the Company on a consistent basis.
As it relates to future projections for the Company as well as other forward-looking information described further above, the Company has not provided guidance for comparable GAAP measures or a quantitative reconciliation of forward-looking non-GAAP financial measures to the most directly comparable
The Company's reference to trailing twelve months adjusted EBITDA within this press release refers to the twelve month period ended June 30, 2023 adjusted EBITDA of
Certain of the prior period non-GAAP financial measures presented in the following tables have been adjusted to conform with current period presentation. The following tables reconcile the Company's non-GAAP financial measures (unaudited) to their most directly comparable GAAP (unaudited) financial measures (dollars in thousands unless otherwise noted, except per share amounts):
Three Months Ended | Six Months Ended | ||||||
Non-GAAP Operating Income and Margin Reconciliations: | 2023 | 2022 | 2023 | 2022 | |||
Operating income | $ 56,795 | $ 31,903 | $ 106,724 | $ 61,306 | |||
Combination, integration and other acquisition-related expenses (a) | — | 1,831 | — | 5,885 | |||
Restructuring and related charges (credits), net | 1,043 | (1) | 5,015 | 819 | |||
Strategic planning expenses | 579 | 3,112 | 2,666 | 6,200 | |||
— | 929 | — | 2,095 | ||||
Other charges | 344 | 1,031 | 649 | 1,660 | |||
Non-GAAP operating income | $ 58,761 | $ 38,805 | $ 115,054 | $ 77,965 | |||
Non-GAAP operating margin (%) | 11.9 % | 7.9 % | 11.6 % | 8.1 % |
EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin and | Three Months Ended | Six Months Ended | |||||
2023 | 2022 | 2023 | 2022 | ||||
Net income attributable to Quaker Chemical Corporation | $ 29,346 | $ 14,343 | $ 58,880 | $ 34,159 | |||
Depreciation and amortization (b) | 20,834 | 20,856 | 41,344 | 41,583 | |||
Interest expense, net | 12,721 | 6,494 | 25,963 | 11,839 | |||
Taxes on income before equity in net income of associated | 13,830 | 1,374 | 23,363 | 4,240 | |||
EBITDA | 76,731 | 43,067 | 149,550 | 91,821 | |||
Equity loss in a captive insurance company | 430 | 1,781 | 8 | 2,025 | |||
Combination, integration and other acquisition-related (credits) | (475) | 2,248 | (475) | 8,281 | |||
Restructuring and related charges (credits), net | 1,043 | (1) | 5,015 | 819 | |||
Strategic planning expenses | 579 | 3,112 | 2,666 | 6,200 | |||
— | 929 | — | 2,095 | ||||
Currency conversion impacts of hyper-inflationary economies | 1,184 | 36 | 1,640 | 224 | |||
Loss on extinguishment of debt | — | 6,763 | — | 6,763 | |||
Other charges | 750 | 556 | 629 | 707 | |||
Adjusted EBITDA | $ 80,242 | $ 58,491 | $ 159,033 | $ 118,935 | |||
Adjusted EBITDA margin (%) | 16.2 % | 11.9 % | 16.0 % | 12.3 % | |||
Adjusted EBITDA | $ 80,242 | $ 58,491 | $ 159,033 | $ 118,935 | |||
Less: Depreciation and amortization - adjusted (b) | 20,834 | 20,856 | 41,344 | 41,583 | |||
Less: Interest expense, net | 12,721 | 6,494 | 25,963 | 11,839 | |||
Less: Taxes on income before equity in net income of associated | 11,913 | 7,466 | 22,960 | 16,368 | |||
Non-GAAP net income | $ 34,774 | $ 23,675 | $ 68,766 | $ 49,145 |
Three Months Ended | Six Months Ended | ||||||
Non-GAAP Earnings per Diluted Share Reconciliations: | 2023 | 2022 | 2023 | 2022 | |||
GAAP earnings per diluted share attributable to Quaker Chemical | $ 1.63 | $ 0.80 | $ 3.27 | $ 1.91 | |||
Equity loss in a captive insurance company per diluted share | 0.02 | 0.10 | 0.00 | 0.11 | |||
Combination, integration and other acquisition-related (credits) | (0.03) | 0.13 | (0.03) | 0.38 | |||
Restructuring and related charges (credits), net per diluted share | 0.04 | (0.00) | 0.21 | 0.03 | |||
Strategic planning expenses per diluted share | 0.03 | 0.13 | 0.13 | 0.27 | |||
— | 0.04 | — | 0.10 | ||||
Currency conversion impacts of hyper-inflationary economies | 0.06 | 0.00 | 0.09 | 0.01 | |||
Loss on extinguishment of debt per diluted share | — | 0.29 | — | 0.29 | |||
Other charges per diluted share | 0.04 | 0.03 | 0.02 | 0.03 | |||
Impact of certain discrete tax items per diluted share | 0.14 | (0.20) | 0.13 | (0.39) | |||
Non-GAAP earnings per diluted share | $ 1.93 | $ 1.32 | $ 3.82 | $ 2.74 |
(a) | Combination, integration and other acquisition-related (credits) expenses in 2022 included certain legal, financial, and other advisory and consultant costs incurred in connection with the Combination integration activities. These amounts also include expense associated with the Company's other recent acquisitions, including certain legal, financial, and other advisory and consultant costs incurred in connection with due diligence. During both the three and six months ended June 30, 2023, the Company recorded |
(b) | Depreciation and amortization for the three and six months ended June 30, 2023 and the same period of 2022 includes approximately |
(c) | Taxes on income before equity in net income of associated companies – adjusted includes the Company's tax expense adjusted for the impact of any current and deferred income tax expense (benefit), as applicable, of the reconciling items presented in the reconciliation of Net income attributable to Quaker Chemical Corporation to adjusted EBITDA, above, determined utilizing the applicable rates in the taxing jurisdictions in which these adjustments occurred, subject to deductibility. This caption also includes the impact of specific tax charges and benefits in the three and six months ended June 30, 2023 and 2022, which the Company does not consider core to the Company's operations or indicative of future performance. |
Segment Measures and Reconciliations
Segment operating earnings for each of the Company's reportable segments are comprised of the segment's net sales less directly related Cost of goods sold ("COGS") and Selling, general and administrative expenses ("SG&A"). Operating expenses not directly attributable to the net sales of each respective segment, such as certain corporate and administrative costs, Combination, integration and other acquisition-related expenses, and Restructuring and related charges (credits), net, are not included in segment operating earnings. Other items not specifically identified with the Company's reportable segments include Interest expense, net and Other expense, net.
The following table presents information about the performance of the Company's reportable segments (dollars in thousands):
Three Months Ended | Six Months Ended | ||||||
2023 | 2022 | 2023 | 2022 | ||||
Net Sales | |||||||
$ 253,219 | $ 235,809 | $ 504,632 | $ 447,900 | ||||
EMEA | 143,533 | 145,535 | 295,982 | $ 292,354 | |||
98,692 | 111,044 | 194,978 | $ 226,305 | ||||
Total net sales | $ 495,444 | $ 492,388 | $ 995,592 | $ 966,559 | |||
Segment operating earnings | |||||||
$ 69,007 | $ 52,137 | $ 135,132 | $ 97,316 | ||||
EMEA | 25,583 | 20,076 | 53,154 | $ 43,324 | |||
27,989 | 24,922 | 55,641 | $ 49,423 | ||||
Total segment operating earnings | 122,579 | 97,135 | 243,927 | 190,063 | |||
Combination, integration and other acquisition-related expenses | — | (1,832) | — | (5,885) | |||
Restructuring and related (charges) credits, net | (1,043) | 1 | (5,015) | (819) | |||
Non-operating and administrative expenses | (49,950) | (48,579) | (101,721) | (92,042) | |||
Depreciation of corporate assets and amortization | (14,791) | (14,822) | (30,467) | (30,011) | |||
Operating income | 56,795 | 31,903 | 106,724 | 61,306 | |||
Other expense, net | (3,606) | (8,399) | (5,845) | (10,605) | |||
Interest expense, net | (12,721) | (6,494) | (25,963) | (11,839) | |||
Income before taxes and equity in net income of associated | $ 40,468 | $ 17,010 | $ 74,916 | $ 38,862 |
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements can be identified by the fact that they do not relate strictly to historical or current facts. We have based these forward-looking statements on our current expectations about future events, including statements regarding the potential effects of the COVID-19 pandemic, the
Conference Call
As previously announced, the Company's investor conference call to discuss its second quarter of 2023 performance is scheduled for Wednesday, August 2, 2023 at 8:30 a.m. ET. A live webcast of the conference call, together with supplemental information, can be accessed through the Company's Investor Relations website at investors.quakerhoughton.com. You can also access the conference call by dialing 877-269-7756.
About Quaker Houghton
Quaker Houghton is the global leader in industrial process fluids. With a presence around the world, including operations in over 25 countries, our customers include thousands of the world's most advanced and specialized steel, aluminum, automotive, aerospace, offshore, container, mining, and metalworking companies. Our high-performing, innovative and sustainable solutions are backed by best-in-class technology, deep process knowledge and customized services. With approximately 4,600 employees, including chemists, engineers and industry experts, we partner with our customers to improve their operations so they can run even more efficiently, even more effectively, whatever comes next. Quaker Houghton is headquartered in
Quaker Chemical Corporation | |||||||
Three Months Ended | Six Months Ended | ||||||
2023 | 2022 | 2023 | 2022 | ||||
Net sales | $ 495,444 | $ 492,388 | $ 995,592 | $ 966,559 | |||
Cost of goods sold | 317,753 | 342,824 | 644,451 | 670,924 | |||
Gross profit | 177,691 | 149,564 | 351,141 | 295,635 | |||
Selling, general and administrative expenses | 119,853 | 115,830 | 239,402 | 227,625 | |||
Restructuring and related charges (credits), net | 1,043 | (1) | 5,015 | 819 | |||
Combination, integration and other acquisition-related expenses | — | 1,832 | — | 5,885 | |||
Operating income | 56,795 | 31,903 | 106,724 | 61,306 | |||
Other expense, net | (3,606) | (8,399) | (5,845) | (10,605) | |||
Interest expense, net | (12,721) | (6,494) | (25,963) | (11,839) | |||
Income before taxes and equity in net income of associated | 40,468 | 17,010 | 74,916 | 38,862 | |||
Taxes on income before equity in net income of associated | 13,830 | 1,374 | 23,363 | 4,240 | |||
Income before equity in net income of associated companies | 26,638 | 15,636 | 51,553 | 34,622 | |||
Equity in net income of associated companies | 2,755 | (1,265) | 7,381 | (430) | |||
Net income | 29,393 | 14,371 | 58,934 | 34,192 | |||
Less: Net income attributable to noncontrolling interest | 47 | 28 | 54 | 33 | |||
Net income attributable to Quaker Chemical Corporation | $ 29,346 | $ 14,343 | $ 58,880 | $ 34,159 | |||
Per share data: | |||||||
Net income attributable to Quaker Chemical Corporation | $ 1.63 | $ 0.80 | $ 3.28 | $ 1.91 | |||
Net income attributable to Quaker Chemical Corporation | $ 1.63 | $ 0.80 | $ 3.27 | $ 1.91 | |||
Basic weighted average common shares outstanding | 17,892,444 | 17,834,329 | 17,879,629 | 17,830,218 | |||
Diluted weighted average common shares outstanding | 17,921,414 | 17,841,377 | 17,909,906 | 17,847,404 |
Quaker Chemical Corporation | |||
June 30, | December 31, | ||
ASSETS | |||
Current assets | |||
Cash and cash equivalents | $ 189,405 | $ 180,963 | |
Accounts receivable, net | 454,230 | 472,888 | |
Inventories, net | 274,940 | 284,848 | |
Prepaid expenses and other current assets | 65,426 | 55,438 | |
Total current assets | 984,001 | 994,137 | |
Property, plant and equipment, net | 204,732 | 198,595 | |
Right of use lease assets | 40,983 | 43,766 | |
Goodwill | 507,370 | 515,008 | |
Other intangible assets, net | 918,143 | 942,925 | |
Investments in associated companies | 91,960 | 88,234 | |
Deferred tax assets | 10,033 | 11,218 | |
Other non-current assets | 33,019 | 27,739 | |
Total assets | $ 2,790,241 | $ 2,821,622 | |
LIABILITIES AND EQUITY | |||
Current liabilities | |||
Short-term borrowings and current portion of long-term debt | $ 19,369 | $ 19,245 | |
Accounts payable | 193,790 | 193,983 | |
Dividends payable | 7,830 | 7,808 | |
Accrued compensation | 35,129 | 39,834 | |
Accrued restructuring | 5,160 | 5,483 | |
Accrued pension and postretirement benefits | 1,579 | 1,560 | |
Other accrued liabilities | 83,681 | 86,873 | |
Total current liabilities | 346,538 | 354,786 | |
Long-term debt | 863,934 | 933,561 | |
Long-term lease liabilities | 24,218 | 26,967 | |
Deferred tax liabilities | 156,247 | 160,294 | |
Non-current accrued pension and postretirement benefits | 29,174 | 28,765 | |
Other non-current liabilities | 33,464 | 38,664 | |
Total liabilities | 1,453,575 | 1,543,037 | |
Equity | |||
Common stock | 17,999 | 17,950 | |
Capital in excess of par value | 934,941 | 928,288 | |
Retained earnings | 513,148 | 469,920 | |
Accumulated other comprehensive loss | (130,108) | (138,240) | |
Total Quaker shareholders' equity | 1,335,980 | 1,277,918 | |
Noncontrolling interest | 686 | 667 | |
Total equity | 1,336,666 | 1,278,585 | |
Total liabilities and equity | $ 2,790,241 | $ 2,821,622 |
Quaker Chemical Corporation | |||
Six Months Ended | |||
2023 | 2022 | ||
Cash flows from operating activities | |||
Net income | $ 58,934 | $ 34,192 | |
Adjustments to reconcile net income to net cash used in operating activities: | |||
Amortization of debt issuance costs | 706 | 2,236 | |
Depreciation and amortization | 40,824 | 41,036 | |
Equity in undistributed earnings of associated companies, net of dividends | (4,207) | 3,400 | |
Deferred compensation, deferred taxes and other, net | 154 | (10,223) | |
Share-based compensation | 7,414 | 5,433 | |
Loss on extinguishment of debt | — | 5,246 | |
Loss (gain) on disposal of property, plant, equipment and other assets | — | 15 | |
Combination and other acquisition-related expenses, net of payments | — | (3,880) | |
Restructuring and related charges, net | 5,015 | 819 | |
Pension and other postretirement benefits | (308) | (2,269) | |
Increase (decrease) in cash from changes in current assets and current liabilities, net of | |||
Accounts receivable | 22,017 | (51,944) | |
Inventories | 11,750 | (58,427) | |
Prepaid expenses and other current assets | (8,925) | (5,558) | |
Change in restructuring liabilities | (5,410) | (797) | |
Accounts payable and accrued liabilities | (11,912) | 32,298 | |
Net cash provided by (used in) operating activities | 116,052 | (8,423) | |
Cash flows from investing activities | |||
Investments in property, plant and equipment | (17,040) | (15,138) | |
Payments related to acquisitions, net of cash acquired | — | (9,383) | |
Proceeds from disposition of assets | — | 85 | |
Net cash used in investing activities | (17,040) | (24,436) | |
Cash flows from financing activities | |||
Payments of long-term debt | (9,439) | (668,500) | |
Proceeds from long-term debt | — | 750,000 | |
(Payments) borrowings on revolving credit facilities, net | (62,778) | 16,703 | |
Payments on other debt, net | (456) | (155) | |
Financing-related debt issuance costs | — | (3,734) | |
Dividends paid | (15,631) | (14,862) | |
Other stock related activity | (712) | (821) | |
Net cash (used in) provided by financing activities | (89,016) | 78,631 | |
Effect of foreign exchange rate changes on cash | (1,554) | (8,600) | |
Net decrease in cash and cash equivalents | 8,442 | 37,172 | |
Cash and cash equivalents at the beginning of the period | 180,963 | 165,176 | |
Cash and cash equivalents at the end of the period | $ 189,405 | $ 202,348 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/quaker-houghton-announces-second-quarter-2023-results-301890747.html
SOURCE Quaker Houghton